Peter Sanguinetti - Australian Pharmaceutical Insider

Australian Pharmaceutical Industries Limited -- Australia Stock  

AUD 1.67  0.04  2.34%

Chief Legal Counsel, Company Secretary

Mr. Peter F. Sanguinetti is General Counsel, Company Secretary of Australian Pharmaceutical Industries Ltd., since November 2007. Mr Sanguinetti BJuris, LLB, GAICD has extensive experience and was previously Company Secretary and General Counsel of Kodak Pty Ltd for 9 years, responsible for legal and company secretarial activities for the Kodak group across Asia. Mr Sanguinetti was also a nonexecutive director of HPAL Limited from January 2005 to November 2007. On 2 June 2009.
  Executive Since 2007      
(61) 3 8855 3401  www.api.net.au

Management Efficiency

The company has return on total asset (ROA) of 4.35 % which means that it generated profit of $4.35 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 10.85 % meaning that it generated $10.85 on every $100 dollars invested by stockholders.
The company has accumulated 93.81 M in total debt with debt to equity ratio (D/E) of 17.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Australian Pharmaceutical Industries Limited has Current Ratio of 1.46 which is within standard range for the sector.

Similar Executives

Entity Summary

Australian Pharmaceutical Industries Limited primarily engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle solutions to pharmacies. Australian Pharmaceutical Industries Limited (API) is traded on Australian Securities Exchange in Australia. It is located in Level 5, 250 Camberwell Road, Camberwall, Victoria 3124, Australia and employs 18 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Australian Pharmaceutical Industries Limited to your portfolio

Top Management

Australian Pharmaceutical Leadership Team
Robert Millner, Director
Esther Holley, Director
Kenneth GundersonBriggs, Director
Stephen Arthurson, Executive
Gerard Masters, Director
Richard Vincent, Executive
Stephen Roche, CEO
Peter Mendo, CFO
Mark Smith, Director
Peter Sanguinetti, Executive
Lee Ausburn, Director
Peter Robinson, Chairman
Kylie Barrie, Executive

Stock Performance

Australian Pharmaceutical Performance Indicators